Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, …
Over the last 12 months, insiders at Elanco Animal Health Incorporated have bought $2.23M and sold $0 worth of Elanco Animal Health Incorporated stock.
On average, over the past 5 years, insiders at Elanco Animal Health Incorporated have bought $2.73M and sold $3.25B worth of stock each year.
Highest buying activity among insiders over the last 12 months: Simmons Jeffrey N (PRESIDENT, CEO AND DIRECTOR) — $2.6M. DOYLE WILLIAM F (director) — $1.5M. HOOVER R DAVID (director) — $1.29M.
The last purchase of 3,500 shares for transaction amount of $51,974 was made by Harrington Michael J (director) on 2024‑08‑22.
2024-08-22 | director | 3,500 0.0007% | $14.85 | $51,974 | -1.06% | |||
2024-08-12 | PRESIDENT, CEO AND DIRECTOR | 100,000 0.02% | $13.01 | $1.3M | +10.66% | |||
2024-05-21 | director | 15,000 0.0031% | $16.98 | $254,700 | -13.17% | |||
2024-03-08 | director | 3,100 0.0006% | $16.29 | $50,494 | -10.94% | |||
2024-03-08 | director | 15,000 0.003% | $16.30 | $244,500 | -10.94% | |||
2024-03-06 | director | 20,000 0.0041% | $16.14 | $322,808 | -8.66% | |||
2023-03-14 | director | 5,000 0.001% | $9.55 | $47,750 | +22.55% | |||
2023-03-13 | director | 5,000 0.001% | $9.46 | $47,288 | +23.79% | |||
2023-03-10 | PRESIDENT, CEO AND DIRECTOR | 15,000 0.0031% | $9.60 | $143,972 | +19.75% | |||
2023-03-03 | director | 10,000 0.002% | $11.13 | $111,300 | +1.35% | |||
2022-11-11 | director | 7,500 0.0015% | $13.24 | $99,267 | -16.80% | |||
2022-09-09 | 20,000 0.0041% | $15.18 | $303,614 | -21.00% | ||||
2022-09-09 | SEE REMARKS | 13,400 0.0027% | $14.90 | $199,660 | -21.00% | |||
2022-09-09 | PRESIDENT, CEO AND DIRECTOR | 30,000 0.006% | $14.54 | $436,146 | -21.00% | |||
2022-09-09 | 20,000 0.0041% | $15.03 | $300,500 | -21.00% | ||||
2022-05-20 | 20,000 0.0039% | $23.33 | $466,538 | -46.79% | ||||
2022-05-11 | 20,000 0.0043% | $22.03 | $440,568 | -37.18% | ||||
2022-03-02 | director | 10,000 0.002% | $29.00 | $290,000 | -46.97% | |||
2022-03-01 | director | 10,000 0.002% | $28.66 | $286,645 | -46.86% | |||
2022-03-01 | director | 2,000 0.0004% | $28.48 | $56,958 | -46.86% |
HOOVER R DAVID | director | 185000 0.0374% | $13.38 | 23 | 0 | <0.0001% |
Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | 145000 0.0293% | $13.38 | 7 | 0 | <0.0001% |
Harrington Michael J | director | 81094 0.0164% | $13.38 | 6 | 0 | <0.0001% |
DOYLE WILLIAM F | director | 76330 0.0154% | $13.38 | 2 | 0 | |
BILBREY JOHN P | director | 41722 0.0084% | $13.38 | 6 | 0 | <0.0001% |
Dodge & Cox | $1.37B | 16.97 | 83.85M | -0.16% | -$2.15M | 0.8 | |
PRIMECAP Management Co | $860.97M | 10.7 | 52.89M | +4.51% | +$37.2M | 0.63 | |
The Vanguard Group | $801.92M | 9.97 | 49.26M | -0.42% | -$3.43M | 0.02 | |
BlackRock | $433.7M | 5.39 | 26.64M | -4.12% | -$18.62M | 0.01 | |
T. Rowe Price | $360.43M | 4.48 | 22.14M | +4% | +$13.88M | 0.04 |